Janux Therapeutics Inc. Gains 229.47%
Tue, Feb 27, 2024 at 07:12 PM
Janux Therapeutics Inc. (JANX:NASDAQ) jumped higher at $49.75, a gain of 229.5%. On Tue, Feb 27, 2024, JANX:NASDAQ hit a New 2-Week High of $49.75. The stock got featured on our News Catalysts scanner on Tue, Feb 27, 2024 at 06:11 PM in the 'PUBLIC OFFERING' category. From Tue, Feb 13, 2024, the stock recorded 77.78% Up Days and 70.00% Green Days
About Janux Therapeutics Inc. (JANX:NASDAQ)
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat...
Top 10 Gainers:
- Janux Therapeutics Inc. (JANX:NASDAQ), 229.47%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 121.02%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 81.94%
- Presto Automation Inc Com (PRST:NASDAQ), 74.05%
- SRAX, Inc. (SRAX:NASDAQ), 66.67%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 62.09%
- Vicarious Surgical Inc. Class A (RBOT:NYSE), 57.11%
- Biora Therapeutics Inc. (BIOR:NASDAQ), 46.67%
- JetAI Inc Com (JTAI:NASDAQ), 44.15%